Navigation Links
Omar S. Manejwala, MD Speaks Out Nationally on Diprivan/Propofol Abuse

In response to the recent media attention on Diprivan (Propofol) abuse, the Farley Center at Williamsburg Place, one of the nation's leading addiction treatment centers, has offered to provide expert consultation about this rare disorder.

Williamsburg, VA (PRWEB) July 17, 2009 -- In response to the recent media attention on Diprivan (Propofol) abuse, the Farley Center at Williamsburg Place, one of the nation's leading addiction treatment centers, has offered to provide expert consultation about this rare disorder. Omar S. Manejwala, M.D., Associate Medical Director for the Farley Center is one of a handful of physicians highly experienced in this area and has appeared nationally recently on programs such as the Early Show on CBS.

Diprivan, is a widely used intravenous sedative medication that is used both for procedures (such as in surgeries or colonoscopies) and for non-procedural sedation. It has been around since the 1980's and is very widely used. It is often described as "milk of amnesia" or "milk of the ICU.

"I've worked with many practitioners who prefer to use it because of its rapid onset and the ability to carefully titrate doses and the rapid recovery afterwards. It has more than a couple of decades of safe, effective use when used appropriately." states Dr. Manejwala.

But only a few cc's more than what's required can trigger fatal respiratory arrest and because Diprivan is such a short-acting medication, heavy abusers must inject it frequently to stay high. As many as 50 to 100 times during a using session is not unheard of. 40% of residents who reportedly abused the anesthetic died from their use of the peril of Diprivan's exquisitely narrow therapeutic window.

Many individuals who are addicted to Diprivan also suffer from Post-Traumatic Stress Disorder (PTSD). Most commonly, these individuals are initially attempting to self-medicate refractory, persistent insomnia. This insomnia can be due to any number of causes including depression, PTSD, alcoholism or addiction to other agents. With repeated self-administration, these individuals develop the brain disease of addiction and their use becomes compulsive, rather than self-medicating.

Abuse in the Healthcare Industry

Dr. Manejwala indicates that, in his clinical experience, a high percentage of Diprivan abusers are health care practitioners--usually anesthesiologists, nurse anesthetists or operating room technicians. Research indicates that one in five academic anesthesiology training programs reported at least one case of abuse by physicians or other healthcare workers over the past decade. The reported incidence of Propofol abuse has risen fivefold over the last 10 years. While no specific study of outcomes in Diprivan addiction has been conducted, our clinical experience supports strong outcomes in this cohort when appropriate treatment modalities are employed. Dr. Manejwala recommends state-of-the-art addiction treatment for Diprivan addiction by a facility with specific experience treating professionals with Diprivan addiction, and has seen strong outcomes from this approach.

"It's very difficult for individuals who abuse Diprivan to identify with other addicts, and this identification is critical to good outcomes. Since Diprivan addiction is so infrequent, it is really important that Diprivan dependent patients seek treatment at centers that have experience treating this disorder."

The Farley Center at Williamsburg Place is a leading addiction treatment program in the nation known for its work in treating individuals who have Substance Use Disorders, and offers intensive, in-depth psychotherapeutic treatment, safe detoxification, as well as educational and experiential approaches to assist people transition into recovery. Many patients have been diagnosed with complicating medical conditions, co-occurring psychiatric illnesses and/or personality disorders. Considered the leader in treating professionals and working with Physicians Health and Lawyers Assistance Programs, The Farley Center at Williamsburg Place takes pride in being able to prepare the professional to return to their chosen field safely and in recovery.

Dr. Omar S. Manejwala is a board-certified addiction psychiatrist and is also board-certified by the American Board of Addiction Medicine. A graduate of the University of Maryland School of Medicine, he completed his internship and residency in psychiatry at Duke University Medical Center, where he also served as the Executive Chief Resident.

Active in ASAM, having held several leadership positions at the North Carolina Psychiatric Association and the North Carolina Society of Addiction Medicine, Dr. Manejwala is also certified Medical Review Officer. He is a frequent guest speaker on state of the art approaches to modifying traditional "rehab" treatment for alcoholism and drug addiction.

For more information, please visit to learn more about the diagnosis of Diprivan abuse and addiction treatment.

Gina de Peralta Thorne, MS
Director of Business Development
The Farley Center at Williamsburg Place


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. General Colin Powell Speaks Out for Prostate Cancer Prevention
2. Women for Women International Congolese Country Director, Christine Karumba, Speaks Out About the Rape Epidemic in the Democratic Republic of the Congo.
3. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
4. CBM USA stands up and speaks out to world leaders on the International Day for the Eradication of Poverty
5. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
6. National Institute on Drug Abuse Director Nora Volkow Speaks about the Dangers of Narcotics on Azteca Americas Political Forum Issues: Caras y Voces
7. Massachusetts Teacher Facing Unaffordable Mandatory Health Insurance Speaks Out Against CA Mandate Proposal
8. AAFPRS Speaks to the Safety of BOTOX(R) Cosmetic
9. ToysRUs Kicks Off Fundraising Campaign to Benefit Autism Speaks
10. Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2
11. Consumer Advocate Speaks Out Against Bill Allowing Invasions of Medical Privacy; Author Received $21k from Bill Benefactors
Post Your Comments:
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: